BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1166 related articles for article (PubMed ID: 24296588)

  • 1. Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma.
    Huang JL; Zheng L; Hu YW; Wang Q
    Carcinogenesis; 2014 Mar; 35(3):507-14. PubMed ID: 24296588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation.
    Chen CL; Tseng YW; Wu JC; Chen GY; Lin KC; Hwang SM; Hu YC
    Biomaterials; 2015 Mar; 44():71-81. PubMed ID: 25617127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
    He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
    Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin.
    Huang JF; Guo YJ; Zhao CX; Yuan SX; Wang Y; Tang GN; Zhou WP; Sun SH
    Hepatology; 2013 May; 57(5):1882-92. PubMed ID: 23239537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
    Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
    Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
    Peng W; Fan H
    Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNAs in liver cancer: what we know in 2014.
    Zhao J; Greene CM; Gray SG; Lawless MW
    Expert Opin Ther Targets; 2014 Oct; 18(10):1207-18. PubMed ID: 25145388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
    Qiu L; Tang Q; Li G; Chen K
    Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs: critical players in hepatocellular carcinoma.
    Sun J; Bie B; Zhang S; Yang J; Li Z
    Int J Mol Sci; 2014 Nov; 15(11):20434-48. PubMed ID: 25387074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Emerging Role of Long Non-Coding RNAs in the Metastasis of Hepatocellular Carcinoma.
    Chen X; Tang FR; Arfuso F; Cai WQ; Ma Z; Yang J; Sethi G
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31906046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of lncRNAs in hepatocellular carcinoma: opportunities as novel targets for pharmacological intervention.
    Zou H; Shao CX; Zhou QY; Zhu GQ; Shi KQ; Braddock M; Huang DS; Zheng MH
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):331-40. PubMed ID: 26558504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA OR3A4 participates in the angiogenesis of hepatocellular carcinoma through modulating AGGF1/akt/mTOR pathway.
    Li W; Fu Q; Man W; Guo H; Yang P
    Eur J Pharmacol; 2019 Apr; 849():106-114. PubMed ID: 30710550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma.
    Li C; Chen J; Zhang K; Feng B; Wang R; Chen L
    Cell Physiol Biochem; 2015; 36(2):423-34. PubMed ID: 25968300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional long non-coding RNAs in hepatocellular carcinoma.
    Xie C; Li SY; Fang JH; Zhu Y; Yang JE
    Cancer Lett; 2021 Mar; 500():281-291. PubMed ID: 33129957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b.
    Tsang FH; Au SL; Wei L; Fan DN; Lee JM; Wong CC; Ng IO; Wong CM
    Liver Int; 2015 May; 35(5):1597-606. PubMed ID: 25424744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncoding RNA as therapeutic targets for hepatocellular carcinoma.
    George J; Patel T
    Semin Liver Dis; 2015 Feb; 35(1):63-74. PubMed ID: 25632936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasion and metastasis-related long noncoding RNA expression profiles in hepatocellular carcinoma.
    Gao Y; Chen G; Zeng Y; Zeng J; Lin M; Liu X; Liu J
    Tumour Biol; 2015 Sep; 36(10):7409-22. PubMed ID: 25900874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy.
    Yuan SX; Yang F; Yang Y; Tao QF; Zhang J; Huang G; Yang Y; Wang RY; Yang S; Huo XS; Zhang L; Wang F; Sun SH; Zhou WP
    Hepatology; 2012 Dec; 56(6):2231-41. PubMed ID: 22706893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2.
    Huang MD; Chen WM; Qi FZ; Sun M; Xu TP; Ma P; Shu YQ
    Mol Cancer; 2015 Sep; 14():165. PubMed ID: 26336870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge.
    Deng L; Yang SB; Xu FF; Zhang JH
    J Exp Clin Cancer Res; 2015 Feb; 34(1):18. PubMed ID: 25884472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.